BRAWN BIOTECH LTD. Share Price

BRAWN BIOTECH LTD. Share Price

BSE: 530207
|
Trading
|
S Cap
₹ 22.50
+0.00 (0.00%)
1D
Last updated 02 Sep, 2026, 12:15 IST
--
0.00% up today
--
1D LOW
1D HIGH

BRAWN BIOTECH LTD. Returns Calculator

Circuit
L
H
₹21.38
₹23.62
52-week
L
H
₹17.71
₹24.37

About BRAWN BIOTECH LTD.

BRAWN BIOTECH LTD. Share Price
ISIN
INE899B01015
Sector Market Cap
₹ 6.75 Cr

Brawn Biotech Limited is an India-based integrated healthcare company. The Company's pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, And Nutritionals. Its products include Sefix-400 Capsules, Sefix-200 Capsules, Celevran Cream W/C (25GM), Voltran Gel W/C (25GM), Folic Acid Tablets 8P 5MG, Ponstran Capsules 250MG, Fugeran Cream W/C (15GM), Stopin Tablets, Cefixime Tablets 100MG (110), Cefixime Tablets USP 200MG (110), Carbramazepine 200 MG IP Tab, Potassium Chloride for Injection 15% 150mg/ml USP (10 ML), Promethazine HCL Injection 25 MG/ML, Allopurinol 100mg IP Tab, Carbamazepine 100 mg IP Tab, Feme Tab, Bromex Liquid, Salbutamol 4 mg IP Tab, Chlorpheniramine Maleate 4mg Tab, Pheniramine Maleate 25mg Tab, Eracef 500 mg, Erazide 1 Gm Injection, Hyoscine Butyl Bromide (1 ml) IP Inj, Alprazolam 0.5 Mg Tab, and others.

BRAWN BIOTECH LTD. Financial Highlights

  • Revenue: BRAWN BIOTECH LTD. reported revenue of ₹17.43 crore in FY26 vs ₹13.56 crore in FY25. It showed an increase of 28.54% on a yearly basis.
  • Operating Profit: BRAWN BIOTECH LTD. reported an operating profit of ₹0.00 crore in FY26 vs ₹1.80 crore in FY25. It showed an increase of 100.00% on a year-on-year basis.
  • Net Profit: BRAWN BIOTECH LTD. reported a net profit of ₹0.94 crore in FY26 vs ₹1.80 crore in FY25. It showed an increase of 152.22% on a yearly basis.

BRAWN BIOTECH LTD. Quarterly Result Highlights

  • BRAWN BIOTECH LTD. reported revenue of ₹0.12 crore in Jun 2023, compared with ₹0.35 crore in Mar 2023, representing a decrease of 65.71% on a quarter-on-quarter (QoQ) basis.
  • BRAWN BIOTECH LTD. reported an operating loss of ₹0.04 crore in Jun 2023, compared with ₹0.26 crore in Mar 2023, representing a decrease of 115.38% on a quarter-on-quarter (QoQ) basis.
  • BRAWN BIOTECH LTD. reported a loss of ₹0.04 crore in Jun 2023, compared with ₹0.23 crore in Mar 2023, reflecting a decrease of 117.39% on a QoQ basis.
Know more
Promoters
52.94%
FII
0.00%
Other DII
0.00%
Retail and other
46.71%
Mutual funds
0.35%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
6.75
P/E
7.87
P/B
1.56
ROE
21.68%
D/E
0.00
ROCE
0.10%
Div. Yield
0.00%
EPS(TTM)
3.26
Turnover
0.83
EV/EBITDA
165.49
Net Margin
0.00%
Op. Margin
0.00%
ROA
4.07%
Quick Ratio
0.00
Curr. Ratio
1.13
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Brawn Biotech outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Brawn Biotech appears overvalued compared to its peers
Step 1 of 5
Earnings
Very Poor
Brawn Biotech revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

BRAWN BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2023
Revenue0.72
Operating profit0.22
Net profit0.19

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹13.46₹16.49₹22.23₹8.62
Other Income₹0.09₹0.09₹0.01₹0.00
Total Revenue₹13.56₹16.58₹22.24₹8.62
Total Expenses₹15.36₹18.13₹22.65₹10.74
Profit Before Tax-₹1.80-₹1.54-₹0.41-₹2.12
Tax-₹0.06-₹0.30₹0.46-₹0.47
Profit After Tax-₹1.74-₹1.25-₹0.87-₹1.64
EPS - Basic-₹5.68-₹4.15-₹3.04-₹5.48
EPS - Diluted-₹5.68-₹4.15-₹3.04-₹5.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹1.80-₹1.54-₹0.41-₹2.12
Income before WC changes-₹1.64-₹1.49-₹0.34-₹1.93
Change in Assets-₹5.91₹0.16-₹1.01₹0.63
Change in Liabilities₹7.60₹1.30₹1.66₹1.49
Change in WC₹1.69₹1.46₹0.65₹2.12
Cash flow from Operations₹0.05-₹0.03₹0.32₹0.19
Cash flow from Investing-₹0.24-₹0.01-₹0.10-₹0.30
Cash flow from Financing₹0.00₹0.00-₹0.01-₹0.06
Total Cash Flow-₹0.20-₹0.04₹0.21-₹0.17
Cash (Start of the year)₹0.40₹0.44₹0.22₹0.40
Cash (End of the year)₹0.20₹0.40₹0.44₹0.22

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2.99₹1.45₹1.13₹1.60
Current Assets₹17.50₹13.14₹13.40₹12.19
Total Assets₹20.49₹14.59₹14.53₹13.78
Current Liabilities₹9.33₹6.51₹8.05₹6.32
Net Current Asset₹8.17₹6.63₹5.35₹5.87
Non-Current Liabilities₹7.80₹3.02₹0.17₹0.24
Equity Capital₹3.36₹5.07₹6.31₹7.22
Total Equity & Liabilities₹20.49₹14.59₹14.53₹13.78
* All values are in INR Crore
Qty
Bid
1
22.5
800
21.5
100
21.4
0
0
0
0
Ask
Qty
22.6
1000
22.7
1000
22.8
1000
22.9
789
23.5
150
Bid Total: 901
Ask Total: 3939
Buy orders: 19%
Sell orders: 81%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.03
Neutral
ATR (14)
0.78
Neutral
STOCH(9,6)
30.95
Neutral
STOCH RSI (14)
38.58
Neutral
ADX(9)
20.57
Bearish
UO(9)
65.43
Neutral
ROC(12)
5.63
Bullish
WillR(14)
-39.62
Neutral
Period
Simple value
Exponential vaue
5D
23.04
22.85
10D
22.86
22.69
20D
21.79
22.28
50D
21.61
21.7
100D
21.04
21.44
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
BRAWN BIOTECH LTD. Share Price
BRAWN BIOTECH LTD.
Trading
Add Stock
Add Another

BRAWN BIOTECH LTD. Share Price FAQs